The loss or down-regulation of ELF (a Smad3/4 adaptor protein) might be one of reasons for disruption of TGF-β1 signaling, which similarly predicted a poor OS and DFS rate for patients with HCC. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.